与基于组织的前列腺癌基因组测试相关的社会人口因素
Gabriela M Diaz1, Nethusan Sivanesan1, Sebastien Strachan2
1Yale School of Medicine, Department of Urology, New Haven, CT.
Urology
|December 18, 2025
概括
对前列腺癌的基因组分类器测试在社会弱势地区和西班牙裔患者中不太常见. 这些发现揭示了在获得先进风险评估工具方面的人口差异.
科学领域:
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
- 基因组学就是基因组学.
背景情况:
- 基因组分类器 (GC) 有助于局部性前列腺癌 (PCa) 的风险分层.
- 在PCa管理中影响GC采用的因素尚不清楚.
- 通过GC测试可以加强PCa的个性化治疗决策.
研究的目的:
- 调查社会人口统计因素与局部PCa的GC测试之间的关联.
- 确定在PCa护理中使用GC的患者和区域级预测因素.
主要方法:
- 对接受基因组测试的局部PCa患者 (2012-2022) 的回顾性分析.
- 包括临床,区域贫困指数 (ADI) 和医疗保险数据.
- 后勤回归模型来评估ADI和GC测试接收之间的关系.
主要成果:
- 在2103名符合条件的患者中,有40.1%接受了GC检测.
- 在较不贫困地区 (40.9%) 与最贫困地区 (34.6%) 观察到更高的GC测试率.
- 增加的地区贫困,西班牙裔种族和年轻年龄与较低的GC测试几率有关.
结论:
- 在社会经济弱势群体和西班牙裔患者中,PCa的基因组测试利用率较低.
- 在使用自由裁量PCa风险评估工具方面,人口统计学的差异明显.
- 解决GC测试访问的差异对于公平的PCa管理至关重要.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


